Summary
Over 600 cases currently pending in multi-district litigation against Glaxo Smith Kline allege that the anti-anxiety drug Paxil has caused heart defects in infants born to mothers who were prescribed the drug during pregnancy.
Trials are slated to begin in Philadelphia in September and continue into next year.See the full content of this document
Extract
Attorneys Prepare for Pending Paxil Litigation
The plaintiffs are basing their allegations on a 2005 study by Glaxo Smith Kline of another drug that later found a link between Paxil and birth defects.
Andy Vickery, who practices at Vickery, ...See the full content of this document
Sponsored links
